Clinical trial
Strategies to Improve Islet Survival
NCT00464555 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00464555 |
|---|---|
| Title | Strategies to Improve Islet Survival |
| Official title | Strategies to Improve Long Term Islet Graft Survival |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug, Procedure |
| Interventions | Islet transplant, Antithymocyte globulin, Basiliximab, Lisofylline, Sirolimus, Tacrolimus |
| Enrollment | 5 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2011 |
| Completion | Feb 1, 2014 |
| First posted | Apr 23, 2007 |
| Last update posted | Apr 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: